0000899243-22-004607.txt : 20220203 0000899243-22-004607.hdr.sgml : 20220203 20220203163041 ACCESSION NUMBER: 0000899243-22-004607 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220201 FILED AS OF DATE: 20220203 DATE AS OF CHANGE: 20220203 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Waisbourd Ram CENTRAL INDEX KEY: 0001792064 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39122 FILM NUMBER: 22588863 MAIL ADDRESS: STREET 1: 535 MISSION STREET STREET 2: 14TH FLOOR CITY: SAN FRANCISCO STATE: CA ZIP: 94105 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: 89bio, Inc. CENTRAL INDEX KEY: 0001785173 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 831114349 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 535 MISSION STREET STREET 2: 14TH FLOOR CITY: SAN FRANCISCO STATE: CA ZIP: 94105 BUSINESS PHONE: 4155004614 MAIL ADDRESS: STREET 1: 535 MISSION STREET STREET 2: 14TH FLOOR CITY: SAN FRANCISCO STATE: CA ZIP: 94105 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2022-02-01 0 0001785173 89bio, Inc. ETNB 0001792064 Waisbourd Ram C/O 89BIO, INC. 142 SANSOME STREET, 2ND FLOOR SAN FRANCISCO CA 94104 0 1 0 0 See Remarks Common Stock 2022-02-01 4 M 0 4000 1.93 A 4000 D Common Stock 2022-02-01 4 M 0 3000 1.93 A 7000 D Common Stock 2022-02-01 4 S 0 7000 5.70 D 0 D Stock Option (Right to Buy) 1.93 2022-02-01 4 M 0 4000 0.00 D 2028-11-09 Common Stock 4000 14203 D Stock Option (Right to Buy) 1.93 2022-02-01 4 M 0 3000 0.00 D 2029-10-01 Common Stock 3000 3106 D This transaction was executed pursuant to a Rule 10b5-1 trading plan in multiple trades at prices ranging from $5.43 to $5.97. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected. This option represents a right to purchase a total of 102,203 shares of the Issuer's common stock, one quarter of which vested on May 1, 2019, with the remaining three quarters vesting in equal quarterly installments over the following three years. This option represents a right to purchase a total of 20,106 shares of the Issuer's common stock, one quarter of which vested on May 1, 2019, with the remaining three quarters vesting in equal quarterly installments over the following three years. Chief Operating Officer and Chief Business Officer /s/ Ryan A. Murr, as attorney-in-fact for Ram Waisbourd 2022-02-03